This study compared the safety and duration two previously approved FDA neuromodulators (Jeuveau and Botox) when different dosages are used. Dr. Cox served as principal investigator. This study began in April of 2022 and ended in August of 2023.
This study compared the safety and duration two previously approved FDA neuromodulators (Jeuveau and Botox) when different dosages are used. Dr. Cox served as principal investigator. This study began in April of 2022 and ended in August of 2023.
Questions? Text (919) 403-6200 to schedule or chat.
Aesthetic Solutions Will Be Closed Friday, 7/3/26, and reopen monday, 7/6/26.
For Medical emergencies, please call 911.
To reach the provider on call or to leave a message for our administrative team regarding an appointment, call 919-403-6200.